Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease (Q38084920)

28 August 2017

title

Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease (English)

1 reference

28 August 2017

3

1 reference

28 August 2017

4

Raymond Vanholder

1 reference

28 August 2017

Marijn M Speeckaert

1

1 reference

28 August 2017

Reinhart Speeckaert

series ordinal

2

1 reference

28 August 2017

Joris R Delanghe

series ordinal

5

1 reference

28 August 2017

language of work or name

1 reference

27 February 2013

1 reference

Journal of Clinical Immunology

28 August 2017

published in

1 reference

28 August 2017

volume

33

1 reference

28 August 2017

issue

5

1 reference

28 August 2017

page(s)

881-890

1 reference

Pentraxin-3 expression in acute renal allograft rejection.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

An integrated view of humoral innate immunity: pentraxins as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Killing by neutrophil extracellular traps: fact or folklore?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Long pentraxin 3 in pulmonary infection and acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Pentraxins in innate immunity: lessons from PTX3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Dual function of the long pentraxin PTX3 in resistance against pulmonary infection with Klebsiella pneumoniae in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Impaired endothelial function and elevated levels of pentraxin 3 in early‐onset preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

The soluble pattern recognition receptor pentraxin-3 in innate immunity, inflammation and fertility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

PTX3 interacts with inter-alpha-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Pathogen Recognition by the Long Pentraxin PTX3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Genetic variation in pentraxin (PTX) 3 gene associates with PTX3 production and fertility in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Human pentraxin 3 binds to the complement regulator c4b-binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Regulation of leukocyte recruitment by the long pentraxin PTX3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Leucocyte recruitment in inflammation and novel endogenous negative regulators thereof

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Pentraxins, humoral innate immunity and tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Endothelial pentraxin 3 contributes to murine ischemic acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

TLR4 activation mediates kidney ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Ischemia and reperfusion--from mechanism to translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

The proteomic profile of circulating pentraxin 3 (PTX3) complex in sepsis demonstrates the interaction with azurocidin 1 and other components of neutrophil extracellular traps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

The impact of early cytomegalovirus infection and disease in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

The C-terminus of complement factor H is essential for host cell protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Atypical hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Pentraxins, anti-pentraxin antibodies, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Uric Acid and Pentraxin-3 Levels Are Independently Associated with Coronary Artery Disease Risk in Patients with Stage 2 and 3 Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Pentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Inflammatory Mechanisms in Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

21 January 2018

Small-Vessel Vasculitis

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Systemic sclerosis. A vascular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Pentraxin 3 as a new biomarker of peritoneal injury in peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Pentraxins in nephrology: C-reactive protein, serum amyloid P and pentraxin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Pathogenesis of Henoch-Schönlein purpura nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Recent insights in inflammation-associated wasting in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10875-013-9879-0

Plasma sTWEAK and PTX3: New determinant tools of cardiovascular outcome also in patients with CKD

21 January 2018

1 reference

12 December 2020

Changes in circulating biomarkers during a single hemodialysis session

1 reference

12 December 2020

Markers of inflammation before and during peritoneal dialysis

1 reference

12 December 2020

Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines.

1 reference

12 December 2020

The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells

1 reference

12 December 2020

Inflammation markers, chronic kidney disease, and renal replacement therapy

1 reference

12 December 2020

Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12

1 reference

12 December 2020

Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites

1 reference

12 December 2020

Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients

1 reference

12 December 2020

Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease

1 reference

12 December 2020

A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients

1 reference

12 December 2020

Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis

1 reference

12 December 2020

Cytomegalovirus infection of vascular cells induces expression of pro-inflammatory adhesion molecules by paracrine action of secreted interleukin-1beta

1 reference

12 December 2020

10.1007/S10875-013-9879-0

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1029046338

0 references

1 reference